Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications